Clinical trials
Prostatic Neoplasms trials in Brazil with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 6 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Instituto do Cancer do Estado de São Paulo | 4 |
| University of Sao Paulo | 3 |
| Hospital de Transplante Doutor Euryclides de Jesus Zerbini | 2 |
| Applied Biology, Inc. | 1 |
| Barretos Cancer Hospital | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |
| McMaster University | 1 |
| Rio de Janeiro State University | 1 |
| Universidade Federal de Pernambuco | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 18 |
| Breast Neoplasms | 3 |
| Esophageal Neoplasms | 3 |
| Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Disease | 2 |
| Head and Neck Neoplasms | 2 |
| Kidney Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Uterine Neoplasms | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.